Related Experiment Video
Updated: Sep 4, 2025

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
Published on: January 9, 2020
Single-Cell Mass Spectrometry Enables Insight into Heterogeneity in Infectious Disease
Tra D Nguyen1, Yunpeng Lan1, Shelley S Kane1
1Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma 73019, United States.
Insights
Cellular metabolism varies in host cells during Trypanosoma cruzi infection, impacting Chagas disease. Uninfected cells near infected ones also show metabolic changes, revealing new insights into disease.
Area of Science:
- Infectious Diseases
- Cellular Metabolism
- Host-Pathogen Interactions
Background:
- Cellular heterogeneity is often overlooked in infectious diseases, including Chagas disease (CD).
- Trypanosoma cruzi (T. cruzi) exhibits heterogeneity in replication and drug susceptibility.
- The role of metabolic heterogeneity in host cells during T. cruzi infection remains unexplored.
Purpose of the Study:
- To investigate host cell metabolic heterogeneity during T. cruzi infection.
- To apply a novel single-cell mass spectrometry (SCMS) method for metabolomics analysis in infected cells.
- To understand the impact of T. cruzi on host cell metabolism and adjacent cells.
Main Methods:
- Development of a Single-probe SCMS method compatible with biosafety protocols.
- Acquisition of metabolomics data from individual host cells during T. cruzi infection in vitro.
- Comparative analysis of metabolic profiles between infected, uninfected, and control cells.
Main Results:
- Demonstrated significant heterogeneity in the metabolic response of host cells to T. cruzi infection.
- Identified divergent metabolic profiles in parasite-infected cells compared to control cells.
- Observed metabolic impacts in uninfected cells adjacent to infected cells, with notable increases in glycerophospholipids.
Conclusions:
- Host cell metabolic heterogeneity plays a role in the pathogenesis of Chagas disease.
- The study provides novel insights into host-parasite interactions at the metabolic level.
- This work represents the first bioanalytical SCMS application for studying mammalian-infectious agents, with broad potential for infectious disease research.
Abstract:
Cellular heterogeneity is generally overlooked in infectious diseases. In this study, we investigated host cell heterogeneity during infection with Trypanosoma cruzi (T. cruzi) parasites, causative agents of Chagas disease (CD). In chronic-stage CD, only a few host cells are infected with a large load of parasites and symptoms may appear at sites distal to parasite colonization. Furthermore, recent work has revealed T. cruzi heterogeneity with regard to replication rates and drug susceptibility. However, the role of cellular-level metabolic heterogeneity in these processes has yet to be assessed. To fill this knowledge gap, we developed a Single-probe SCMS (single-cell mass spectrometry) method compatible with biosafety protocols, to acquire metabolomics data from individual cells during T. cruzi infection. This study revealed heterogeneity in the metabolic response of the host cells to T. cruzi infection in vitro. Our results showed that parasite-infected cells possessed divergent metabolism compared to control cells. Strikingly, some uninfected cells adjacent to infected cells showed metabolic impacts as well. Specific metabolic changes include increases in glycerophospholipids with infection. These results provide novel insight into the pathogenesis of CD. Furthermore, they represent the first application of bioanalytical SCMS to the study of mammalian-infectious agents, with the potential for broad applications to study infectious diseases.
More Related Videos
07:55Integrated Cell Manipulation Platform Coupled with the Single-probe for Mass Spectrometry Analysis of Drugs and Metabolites in Single Suspension Cells
Published on: June 21, 2019
09:34A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
Published on: October 25, 2018